Vitamin B6 is beneficial in many ways, notably for its role in maintaining a strong immune system. However, when pancreatic cancer develops, its cells also need vitamin B6 to replicate. During the ensuing tug of war over a limited supply of vitamin B6, pancreatic cancer almost always emerges as the victor. A researcher at the University of Oklahoma College of Medicine is following a promising trail of clues in an effort to reverse that reality.

$3.2 Million Grant to Fund Studies into New Technologies for Earlier Cancer Detection

OU Health Stephenson Cancer Center at the University of Oklahoma is joining the National Cancer Institute’s new Cancer Screening Research Network to study promising approaches for cancer screening, especially among Oklahomans with high cancer risk and limited access to screening services. The research is funded by a $3.2 million grant from the National Cancer Institute (NCI), part of the National Institutes of Health.

Michael A. Schade has been named the interim chief innovation and corporate officer for the University of Oklahoma and the interim executive director of the OU Office of Innovation and Corporate Partnerships (OICP), effective immediately.

Britta Ostermeyer, M.D., MBA, chair of the Department of Psychiatry and Behavioral Sciences in the University of Oklahoma College of Medicine at OU Health Sciences, was recently honored by the American Academy of Psychiatry and the Law (AAPL) for her service to the organization and dedication to forensic psychiatry, a field at the intersection of mental illness and the law.